Profile picture of Neha Aggarwal

Dr Neha Aggarwal

Profile picture of Neha Aggarwal

MBBS, FRACP

Medical Oncologist
Call
Enquire
Referrals

Biography

Dr Neha Aggarwal is a medical oncologist at Icon Cancer Centre Canberra. She undertook physician and specialist oncology training in Australia, including a two-year fellowship in early phase clinical trial and drug development at The Kinghorn Cancer Centre, Sydney. With a strong passion for clinical and translational research, Dr Aggarwal is currently pursuing a PhD investigating immune evasion in small cell lung cancer. She is an active investigator on several clinical trials at Canberra Hospital.

Dr Aggarwal maintain affiliations with several national and international research institutions including the American Society of Clinical Oncology (ASCO), Medical Oncology Group of Australia (MOGA) and Thoracic Oncology Group of Australia (TOGA). Outside of Icon, she is a clinical lecturer at the Australian National University Medical School, providing educational support to medical students, basic and advanced physician trainees. Dr Aggarwal also holds medical oncology staff specialist appointments at Canberra Hospital and South East Regional Hospital, Moruya.

She speaks fluent English and Hindi and looks forward to caring for patients and their loved ones in their preferred language. Her clinical experience covers a broad range of solid tumour malignancies with a special interest in thoracic malignancies (including lung cancer and mesothelioma), genitourinary cancers (including prostate cancer, renal cancer, bladder cancer and testicular cancer), breast cancer and central nervous system (CNS) malignancies.

Publications

  • MOGA 2022: Impact of Covid-19 on early phase clinical trials recruitment and treatment in a major metropolitan phase 1 unit: Neha Aggarwal Jyoti Parmar, Oksana Zdanska, Jacob Yousif, Joshua Hurwitz, Eleanor Handel, Amy Prawira, Anthony Joshua, Rasha Cosman Jenny (Jia) Liu 

  • Poster Presentation at PCF Retreat 2021: Interim Results of Bipolar Androgen Therapy+Carboplatinin Men with Metastatic Castration-Resistant Prostate Cancer(mCRPC)(HIGH TecCH-ArmB) 

  • ASCO 2021, , Journal of Clinical Oncology 2021 39:15_suppl, e14574-e14574 Ronghua Zhao, Rasha Cosman, Neha Aggarwal, Aaron O’Grady, Eugene Hsu, Luke Ardolino, Huiqun Xia, Yiting Chi, Shi Qui, Yanal Murad, Erica Lee, William Jia, and Anthony M. Joshua R. Zhao: Initial results from a first in human trial incorporating accelerated dose titration of a novel immune simulating oncolytic virus -VG161: Abstract accepted at ASCO 2021, Journal of Clinical Oncology 2021 39:15_suppl, e14574-e14574  

  • Gregory Gaughran, Neha Aggarwal, Bruce Shadbolt, and Robin Stuart-Harris: The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer, Breast Cancer Management 2020 9:4  

  • N.Aggarwal, D.Yip: A Retrospective Analysis of NAPOLI Chemotherapy (Nanoliposomal Irinotecan +5 Flurouracil and Leucovorin as Second and Third line Treatment Of Metastatic Pancreatic Cancer in Canberra 

Special Interests

Dr Neha Aggarwal accepts referrals for all cancer types, with a special clinical interest in:

  • Brain and spine (CNS) cancer
  • Breast cancer
  • Genitourinary cancer
  • Lung cancer
  • Prostate cancer

Languages spoken

  • English
  • Hindi

Icon Locations

Visiting Locations

  • Canberra Hospital  
  • South East Regional Hospital, Moruya  

Affiliations & Memberships

  • ACT Health Human Research Ethics Committee (HREC) 
  • American Society of Clinical Oncology (ASCO)  
  • Australasian Lung Cancer Trial Group (ALTG) 
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) 
  • Clinical Oncology Society of Australia (COSA) 
  • Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COGNO) 
  • European Society of Clinical Oncology (ESMO) 
  • Medical Oncology Group of Australia (MOGA) 
  • Royal Australasian College of Physicians (RACP)
  • Thoracic Oncology Group of Australia (TOGA)

Publications

  • MOGA 2022: Impact of Covid-19 on early phase clinical trials recruitment and treatment in a major metropolitan phase 1 unit: Neha Aggarwal Jyoti Parmar, Oksana Zdanska, Jacob Yousif, Joshua Hurwitz, Eleanor Handel, Amy Prawira, Anthony Joshua, Rasha Cosman Jenny (Jia) Liu 

  • Poster Presentation at PCF Retreat 2021: Interim Results of Bipolar Androgen Therapy+Carboplatinin Men with Metastatic Castration-Resistant Prostate Cancer(mCRPC)(HIGH TecCH-ArmB) 

  • ASCO 2021, , Journal of Clinical Oncology 2021 39:15_suppl, e14574-e14574 Ronghua Zhao, Rasha Cosman, Neha Aggarwal, Aaron O’Grady, Eugene Hsu, Luke Ardolino, Huiqun Xia, Yiting Chi, Shi Qui, Yanal Murad, Erica Lee, William Jia, and Anthony M. Joshua R. Zhao: Initial results from a first in human trial incorporating accelerated dose titration of a novel immune simulating oncolytic virus -VG161: Abstract accepted at ASCO 2021, Journal of Clinical Oncology 2021 39:15_suppl, e14574-e14574  

  • Gregory Gaughran, Neha Aggarwal, Bruce Shadbolt, and Robin Stuart-Harris: The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer, Breast Cancer Management 2020 9:4  

  • N.Aggarwal, D.Yip: A Retrospective Analysis of NAPOLI Chemotherapy (Nanoliposomal Irinotecan +5 Flurouracil and Leucovorin as Second and Third line Treatment Of Metastatic Pancreatic Cancer in Canberra 

Search

Contact us
Become a patient